Therapeutics For Our Pets
Monoclonal antibodies (mAbs)
for modern veterinary practices
Developing Life-Changing Therapeutics For Our Pets
Monoclonal antibodies (mAbs) for modern veterinary practices
To bring safe and effective mAb therapies to our dog and cat family members
Monoclonal antibodies (mAbs) have revolutionized the treatment of diseases in humans. Our dogs and cats suffer from many of the same chronic diseases as their human counterparts; however, mAbs technology has been underdeveloped for our furry friends.
At VETmAb BIO, we’re taking advantage of human validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we are opening up new possibilities for the treatment of various diseases in dogs and cats for which there are currently sub-par or no approved therapies.
Implementing first-in-class technology and processes
Our proven team of scientists and researchers is developing mAbs to find treatments for crippling and hard-to-treat conditions in both dogs and cats. The current management of these diseases impacts the entire family because there are no approved therapies, therefore opening up new market opportunities.
A world-renowned team with decades of experience
The VETmAb BIO team brings together the best talent in animal health. Our proven team has decades of experience in the industry and is working together for a second time to develop life-changing therapies for dogs and cats facing debilitating diseases. We are a team of passionate animal lovers who are laser-focused on our mission to improve the health of our beloved dogs and cats.
OPPORTUNITIES FOR PARTICIPATION
Sign your clinic up
for our clinical trials
STAY CONNECTED WITH US
Receive research updates, clinical trial information, and more.
"*" indicates required fields